Allogeneic Haematopoietic Stem Cell Transplantation From a Matched Donor in Patients With Chronic Myeloid Leukemia Failing to Gain Normal Hemopoiesis Under TKIs Therapy
Phase of Trial: Phase II
Latest Information Update: 11 Apr 2018
At a glance
- Drugs Bosutinib (Primary)
- Indications Myeloid leukaemia
- Focus Therapeutic Use
- 06 Apr 2018 Planned End Date changed from 1 Jun 2018 to 1 Jan 2019.
- 06 Apr 2018 Planned primary completion date changed from 1 Jun 2018 to 1 Jan 2019.
- 10 Jun 2017 Biomarkers information updated